• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Trial of Lopinavir-Ritonavir in Covid-19. Reply.

作者信息

Cao Bin, Zhang Dingyu, Wang Chen

机构信息

China-Japan Friendship Hospital, Beijing, China

Jin Yin-tan Hospital, Wuhan, China.

出版信息

N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5.

DOI:10.1056/NEJMc2008043
PMID:32369286
Abstract
摘要

相似文献

1
A Trial of Lopinavir-Ritonavir in Covid-19. Reply.洛匹那韦-利托那韦治疗新冠肺炎的试验。回复。
N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5.
2
A Trial of Lopinavir-Ritonavir in Covid-19.洛匹那韦-利托那韦治疗新冠病毒病的一项试验
N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5.
3
A Trial of Lopinavir-Ritonavir in Covid-19.洛匹那韦-利托那韦治疗新冠肺炎的试验
N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5.
4
A Trial of Lopinavir-Ritonavir in Covid-19.洛匹那韦-利托那韦治疗新冠肺炎的试验
N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5.
5
A Trial of Lopinavir-Ritonavir in Covid-19.洛匹那韦-利托那韦治疗新冠肺炎的试验
N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5.
6
A Trial of Lopinavir-Ritonavir in Covid-19.洛匹那韦-利托那韦治疗新冠肺炎的试验
N Engl J Med. 2020 May 21;382(21):e68. doi: 10.1056/NEJMc2008043. Epub 2020 May 5.
7
Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.洛匹那韦利托那韦治疗的 2 例 COVID-19 患者出现血清素综合征。
J Neurol Sci. 2020 Aug 15;415:116944. doi: 10.1016/j.jns.2020.116944. Epub 2020 May 27.
8
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?洛匹那韦/利托那韦用于新冠肺炎患者：也许可以，但用什么剂量呢？
J Antimicrob Chemother. 2020 Sep 1;75(9):2704-2706. doi: 10.1093/jac/dkaa190.
9
[Drug interaction monitoring of lopinavir/ritonavir in COVID-19 patients with cancer].[新冠肺炎合并癌症患者中洛匹那韦/利托那韦的药物相互作用监测]
Zhonghua Nei Ke Za Zhi. 2020 May 1;59(5):400-404. doi: 10.3760/cma.j.cn112138-20200219-00097.
10
Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19).洛匹那韦和利托那韦在2019冠状病毒病（COVID-19）住院患者中的药代动力学
Ann Intern Med. 2020 Oct 20;173(8):670-672. doi: 10.7326/M20-1550. Epub 2020 May 12.

引用本文的文献

1
Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort.重新利用的药物洛匹那韦-利托那韦和达芦那韦-利托那韦在住院COVID-19患者中的比较疗效：来自三级中心队列的见解。
Front Cell Infect Microbiol. 2025 Jan 16;14:1496176. doi: 10.3389/fcimb.2024.1496176. eCollection 2024.
2
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2.重新利用临床可用药物和疗法针对致病靶点来对抗新型冠状病毒。
MedComm (2020). 2023 May 14;4(3):e254. doi: 10.1002/mco2.254. eCollection 2023 Jun.
3
Dynamics, behaviours, and anomaly persistence in cryptocurrencies and equities surrounding COVID-19.
新冠疫情期间加密货币与股票的动态、表现及异常持续性
Physica A. 2021 May 15;570:125831. doi: 10.1016/j.physa.2021.125831. Epub 2021 Feb 12.
4
Chronic Administration of COVID-19 Drugs Fluvoxamine and Lopinavir Shortens Action Potential Duration by Inhibiting the Human Ether-à-go-go-Related Gene and Cav1.2.长期服用新冠药物氟伏沙明和洛匹那韦可通过抑制人类去极化相关基因和Cav1.2来缩短动作电位时程。
Front Pharmacol. 2022 Jul 7;13:889713. doi: 10.3389/fphar.2022.889713. eCollection 2022.
5
Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and Studies.重新利用美国食品药品监督管理局（FDA）批准的药物对抗严重急性呼吸综合征冠状病毒2（SARS-CoV-2）木瓜样蛋白酶：计算、生化及研究
Front Microbiol. 2022 May 10;13:877813. doi: 10.3389/fmicb.2022.877813. eCollection 2022.
6
The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis.连花清瘟胶囊/颗粒与传统药物临床应用不良反应的Meta分析
Front Pharmacol. 2022 Jan 27;13:764774. doi: 10.3389/fphar.2022.764774. eCollection 2022.
7
Chest Computed Tomography (CT) as a Predictor of Clinical Course in Coronavirus Disease.胸部计算机断层扫描 (CT) 预测冠状病毒病的临床病程。
Med Sci Monit. 2021 Jun 3;27:e931285. doi: 10.12659/MSM.931285.
8
Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects.关于应对 COVID-19 的抗病毒策略的最新进展：未满足的需求和前景。
Front Immunol. 2021 Feb 5;11:616595. doi: 10.3389/fimmu.2020.616595. eCollection 2020.
9
COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm.新冠病毒肺炎：芦可替尼对炎症“逃逸”的高度抑制以避免细胞因子风暴
Front Oncol. 2021 Jan 8;10:599502. doi: 10.3389/fonc.2020.599502. eCollection 2020.
10
Confronting the threat of SARS-CoV-2: Realities, challenges and therapeutic strategies (Review).应对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的威胁：现状、挑战与治疗策略（综述）
Exp Ther Med. 2021 Feb;21(2):155. doi: 10.3892/etm.2020.9587. Epub 2020 Dec 17.